Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
Conde-Taboada
A
A
de la Torre
C
C
Feal
C
C
Mayo
E
E
Gonzalez-Sixto
B
B
Cruces
M J
MJ
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D009506:Nevus / Q000139:chemically induced; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000139:chemically induced
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin